MINNEAPOLIS, Aug. 7 /PRNewswire-FirstCall/ -- Uroplasty, Inc. announced that it will host an audio conference call on August 13, 2007 at 2:00 pm central time to present results for the first quarter of fiscal 2008 ended June 30, 2007. David Kaysen, President and Chief Executive Officer and Medi Jiwani, Vice President, Chief Financial Officer and Treasurer will host the call. Listeners wishing to participate in the conference call should call toll free at 1-888-321-3075. The conference call ID number is 911-1397. A digital recording at toll free telephone number 1-877-519-4471 (ID number 911-1397) will be available starting about two hours after the completion of the conference call through September 12, 2007.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative, proprietary products for the treatment of voiding dysfunctions. Our minimally invasive products treat urinary and fecal incontinence, symptoms of overactive bladder and vesicoureteral reflux. Additionally, some of our soft-tissue bulking agent products are used for the treatment of vocal cord rehabilitation and for augmentation or restoration of soft tissue defects in plastic surgery indications. Some of our products are not approved for use in the U.S.
FOR FURTHER INFORMATION: Visit Uroplasty’s web page at http://www.uroplasty.com or contact Mr. Kaysen, President & CEO, or Medi Jiwani, Vice President, CFO and Treasurer.
UROPLASTY, INC. 5420 Feltl Road Minnetonka, Minnesota 55343 Tel: 952.426.6140 Fax: 952.426.6199
Uroplasty, Inc.
CONTACT: David Kaysen, President and CEO, or Medi Jiwani, Vice President,CFO and Treasurer, both of Uroplasty, Inc., +1-952-426-6140, fax+1-952-426-6199
Web site: http://www.uroplasty.com/
